Acute exacerbation of major depressive disorder following valbenazine treatment for tardive dyskinesia: A case report

Abstract Background Tardive dyskinesia (TD) is a movement disorder associated with long‐term use of dopamine receptor‐blocking agents. Valbenazine, a selective vesicular monoamine transporter 2 (VMAT2) inhibitor, effectively reduces TD symptoms, but it may also trigger or worsen depressive symptoms...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Fumiaki Yano, Yasunori Oda, Yuki Hirose, Fumiaki Yamasaki, Yusuke Nakata, Tomihisa Niitsu
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2025-09-01
Serija:	PCN Reports
Teme:	antipsychotics depression tardive dyskinesia (TD) valbenazine vesicular monoamine transporter 2 (VMAT2) inhibitors
Online dostop:	https://doi.org/10.1002/pcn5.70204
Oznake:	Označite Brez oznak, prvi označite!